The perioperative metabolic state is a key predictor of clinical outcome after cardiac surgery. In particular, stress hyperglycemia – an acute increase in blood glucose due to surgical and inflammatory stress reactions – correlates closely with increased complication and mortality rates. The stress hyperglycemia ratio (SHR) links acute glucose levels to long-term glycemic status (HbA1c), providing a robust method to estimate mortality risk in the short and long term. In this comprehensive summary, we present the key findings of the recent study by Pei et al [4] and discuss how SHR-based algorithms can help to identify patients early and make individualized treatment decisions.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Galenic systems
Advantages of topical pharmacotherapy – Update 2025
- Psychedelics and related drug classes
Ritual, party or new therapy? Psychedelics and more: clinically illuminated
- Acute sinusitis: real-world study on first-line therapy
Focusing on a rational therapeutic approach beyond antibiotics
- DOAK optimization, ABC pathway and lessons learned from the FXI/XIa pipeline
Stroke prevention for atrial fibrillation 2025
- Prurigo nodularis and AD
Effective itch relief through inhibition of the IL-31 signaling pathway
- From symptom to diagnosis
Abdominal pain – Hernias
- "Survey of Health, Ageing and Retirement in Europe" (SHARE)
 
						
						 
					 
			 
						 
						 
																	 
																	 
																	 
																	 
																	 
																	 
																	